ACS Nano · 2024 · 22 citations · 33 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAdjuvant ImmunotherapyAntitumor T Cell ResponsesCancer ImmunotherapyCancer VaccinesImmunotherapy For Brain TumorsT Cell Responses To TumorsAntigen Presenting CellsCell ActivationDendritic Cell-t Cell InteractionExosome-based TherapyExosomesGlioblastoma ImmunologyGlioblastoma ImmunotherapyImmunosuppressive Microenvironment
One key challenge in postoperative glioblastoma immunotherapy is to guarantee a potent and durable T-cell response, which is restricted by the immunosuppressive microenvironment within the lymph nodes (LNs). Here, we develop an in situ sprayed exosome-cross-linked gel that acts as an artificial LN structure to directly activate the tumor-infiltrating T cells for prevention of glioma recurrence. Briefly, this gel is generated by a bio-orthogonal reaction between azide-modified chimeric exosomes and alkyne-modified alginate polymers. Particularly, these chimeric exosomes are generated from dendritic cell (DC)-tumor hybrid cells, allowing for direct and robust T-cell activation. The gel structure with chimeric exosomes as cross-linking points avoids the quick clearance by the immune system and thus prolongs the durability of antitumor T-cell immunity. Importantly, this exosome-containing immunotherapeutic gel provides chances for ameliorating functions of antigen-presenting cells (APCs) through accommodating different intracellular-acting adjuvants, such as stimulator of interferon genes (STING) agonists. This further enhances the antitumor T-cell response, resulting in the almost complete elimination of residual lesions after surgery. Our findings provide a promising strategy for postsurgical glioma immunotherapy that warrants further exploration in the clinical arena.
33
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takanori Takebe, Keisuke Sekine, Masahiro Enomura et al. · Nature · 2013 · 2.1K citations
Medicine, Bioengineering, Surgery +14
Jennifer Couzin-Frankel · Science · 2013 · 2K citations
Medicine, Immunology, Oncology +13
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
Andrea Ablasser, Marion Goldeck, Taner Cavlar et al. · Nature · 2013 · 1.6K citations · Full text
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew Chen, Robyn D. Gartrell et al. · Nature Medicine · 2019 · 956 citations
Medicine, Immunology, Oncology +14